Phosphodiesterase inhibitors: haemodynamic effects related to the treatment of cardiac failure.
D000628:Aminophylline / Q000494:pharmacology; D000818:Animals; D002219:Carbamates / Q000494:pharmacology; D006333:Heart Failure / Q000188:drug therapy / Q000503:physiopathology*; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D009200:Myocardial Contraction / Q000187:drug effects; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*; D011799:Quinazolines / Q000494:pharmacology; D013268:Stimulation, Chemical
D002219:Carbamates; D010726:Phosphodiesterase Inhibitors; D011799:Quinazolines; C031720:carbazeran; D000628:Aminophylline; C012675:buquineran